According to Karuna Therapeutics's latest financial reports the company has a price-to-book ratio of 10.0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 9.56 | 59.5% |
2022-12-31 | 6.00 | -22.44% |
2021-12-31 | 7.73 | -3.79% |
2020-12-31 | 8.03 | 59.86% |
2019-12-31 | 5.03 | |
2018-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 1.81 | -81.97% | ๐บ๐ธ USA |